Costs of ankylosing spondylitis in three European countries: the patient's perspective.

Date publication

août 2003

Journal

Annals of the rheumatic diseases

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis

Tous les auteurs :
Boonen A, van der Heijde D, Landewé R, Guillemin F, Spoorenberg A, Schouten H, Rutten-van Mölken M, Dougados M, Mielants H, de Vlam K, van der Tempel H, van der Linden S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/12860729

Résumé

To assess a patient's out of pocket costs, income loss, time consumption, and quality of life (QoL) due to ankylosing spondylitis (AS) in three European countries and to assess variables predicting these outcomes.

Mots clés

Adolescent, Adult, Aged, Belgium, Cost of Illness, Female, Financing, Personal, statistics & numerical data, Follow-Up Studies, France, Health Care Costs, statistics & numerical data, Health Resources, utilization, Humans, Income, statistics & numerical data, Insurance, Health, statistics & numerical data, Male, Middle Aged, Netherlands, Prospective Studies, Quality of Life, Social Security, statistics & numerical data, Spondylitis, Ankylosing, economics, Surveys and Questionnaires, Survival Analysis, Time

Référence

Ann. Rheum. Dis.. 2003 Aug;62(8):741-7